PET scan study using a new tracer for solid tumors
Treatments studied
Part of Cancer, Digestive system, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests a special PET/CT scan using a new tracer (68Ga-FAPI) to help show tumors in the pancreas, bile ducts, stomach, or certain ovarian cancers. It may help doctors better see where cancer is in preparation for surgery or biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having surgery soon to remove or biopsy a pancreatic, bile duct, or stomach lesion
- Or you have early-stage epithelial ovarian cancer surgery, interval debulking, or surgery/biopsy for recurrent ovarian cancer
- You (or your legal representative) can sign informed consent
- You are older than 18 years
- You are not pregnant or breastfeeding
- You have enough kidney function for the scan and are able to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET scan drug (Ga-FAPI-46) to create clearer pictures of pancreatic and bile duct cancers. It may help doctors decide on the best next steps—especially before surgery—by checking tumor size and looking for spread.
This study tests a new type of PET scan (a detailed imaging test) called [68Ga]Ga-FAPI that may help doctors see cancer better and faster than standard scans. You'll receive this experimental scan to see if it improves cancer detection before surgery.
This study tests a new type of PET scan that uses a radioactive tracer called FAPI-74 to find cancer spread in people with pancreatic cancer. The goal is to see if this scan can help doctors better plan treatment.
This study tests a new type of imaging scan called 68Ga-FAPI-PSMA PET that may help doctors better detect and diagnose solid tumors like prostate, liver, ovarian, or endometrial cancer. You would receive the scan before having a biopsy or surgery.
This trial tests a new type of PET scan (Ga68-FAPI-46) to better see if cancer from the colon, rectum, or ovary has spread to the lining of the belly. If you are already scheduled for surgery to remove these cancer spots, this scan may help your doctors plan a more complete operation.
This trial uses a special PET scan (68Ga-FAPI PET/CT) to see how well cancer in the abdomen (peritoneal metastases) is responding to chemotherapy. It may help doctors decide if the treatment is working.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.